Our Pricing

Lansoprazole vs Omeprazole: Strength Comparison

Published on: June 03, 2026

Understanding the lansoprazole vs omeprazole strength comparison helps you choose the right proton pump inhibitor (PPI) for acid reflux, heartburn, or gastro-oesophageal reflux disease (GORD). Both medications are highly effective PPIs licensed in the UK, but they differ in potency, onset time, and duration of acid suppression, making one potentially more suitable than the other depending on your symptoms and medical history.

Lansoprazole vs Omeprazole: Which Is Stronger?

Milligram for milligram, lansoprazole demonstrates slightly greater acid suppression than omeprazole in clinical studies [1]. A standard lansoprazole 30mg dose provides comparable or superior acid control to omeprazole 20mg, the most commonly prescribed PPI strength in the UK [2]. This means lansoprazole may achieve the same therapeutic effect at a lower equivalent dose.

However, 'strength' in PPIs isn't just about milligram potency—it encompasses speed of onset, duration of action, and individual patient response. Lansoprazole typically begins working within 1-2 hours, whilst omeprazole may take 2-4 hours to reach peak plasma concentration [1]. Both medications suppress gastric acid for approximately 24 hours, making once-daily dosing effective for most patients.

Clinical trials show both PPIs achieve healing rates above 80% for erosive oesophagitis after 8 weeks of treatment, with lansoprazole showing marginally faster symptom relief in the first week [2][3]. Your UK prescriber will consider your specific symptoms, medical history, and any concurrent medications when recommending which PPI offers optimal benefit for your individual circumstances.

How Proton Pump Inhibitors Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor class, which works by irreversibly blocking the hydrogen-potassium ATPase enzyme system (the 'proton pump') in gastric parietal cells [1]. This enzyme is responsible for the final step in gastric acid secretion, and blocking it reduces acid production by up to 90% over 24 hours.

PPIs are prodrugs, meaning they require activation in the acidic environment of the parietal cell secretory canaliculus. Once activated, they form covalent bonds with the proton pump, permanently disabling it until new pumps are synthesised—typically within 24-48 hours [1]. This mechanism explains why PPIs provide longer-lasting acid suppression compared to H2 receptor antagonists like ranitidine.

Maximum acid suppression occurs after 3-5 days of consistent daily dosing, as it takes time to inhibit the full population of proton pumps [2]. This is why your prescriber may advise taking PPIs for several days before assessing effectiveness, rather than expecting immediate symptom resolution.

Onset and Duration of Action

Lansoprazole's faster onset makes it particularly suitable for patients requiring rapid symptom relief, whilst omeprazole's well-established safety profile and lower cost make it an excellent first-line option for long-term maintenance therapy. Both medications maintain acid suppression throughout the day when taken before breakfast, ensuring optimal protection during meal-related acid secretion [3].

Dosing: Lansoprazole 30mg vs Omeprazole 20mg

The standard therapeutic dose for GORD is lansoprazole 30mg once daily or omeprazole 20mg once daily [2]. These doses are considered therapeutically equivalent for most indications, though lansoprazole 30mg may provide marginally greater acid suppression in comparative studies [1].

For milder symptoms like occasional heartburn, lansoprazole 15mg or omeprazole 10mg may suffice, whilst severe erosive oesophagitis or Zollinger-Ellison syndrome may require higher doses under specialist guidance. Your UK prescriber will determine the appropriate starting dose based on symptom severity, endoscopy findings if available, and treatment goals.

Both medications are available in capsule form, with lansoprazole also offered as orodispersible tablets (Zoton FasTab) for patients with swallowing difficulties. All PPI formulations should be taken 30-60 minutes before food for optimal absorption and efficacy [3].

Adjusting Your Dose

Never adjust your PPI dose without consulting your prescriber. Whilst both medications are generally safe for short-term use, long-term high-dose PPI therapy requires monitoring for potential risks including vitamin B12 deficiency, hypomagnesaemia, and increased fracture risk in susceptible patients [4]. Your UK clinical team will review your treatment regularly to ensure you're on the lowest effective dose.

Side Effects and Safety Profile

Both lansoprazole and omeprazole share similar side effect profiles, with the most common being headache, diarrhoea, nausea, and abdominal pain—typically affecting fewer than 5% of patients [2][3]. These effects are usually mild and resolve without discontinuation.

Long-term PPI use (beyond 12 months) has been associated with small increased risks of Clostridium difficile infection, community-acquired pneumonia, and reduced absorption of certain nutrients including magnesium, calcium, and vitamin B12 [4]. However, these risks must be balanced against the significant benefits PPIs provide in preventing complications of untreated acid reflux, including Barrett's oesophagus and oesophageal adenocarcinoma.

Drug interactions differ slightly between the two medications. Omeprazole is a moderate inhibitor of CYP2C19, potentially affecting metabolism of clopidogrel, diazepam, and warfarin [3]. Lansoprazole shows less pronounced CYP2C19 inhibition, making it preferable for patients on these medications, though your prescriber will assess all potential interactions during your clinical assessment.

Lansoprazole vs Omeprazole: Cost and Availability

At Cured Pharmacy, omeprazole is available from £9.99 and lansoprazole from £9.99, both requiring a free online consultation with a UK prescriber. Pricing reflects pack size, strength, and whether you choose branded or generic formulations—all of which contain the same active ingredient and meet identical MHRA licensing standards.

Generic omeprazole typically offers the most cost-effective option for long-term maintenance therapy, whilst branded options like Losec provide additional choice for patients with specific preferences. Lansoprazole is available as generic capsules or as Zoton FasTab orodispersible tablets for enhanced convenience.

All PPI treatments at Cured Pharmacy require clinical assessment by a UK-registered prescriber, ensuring the medication is safe and appropriate for your individual circumstances. Your prescriber will review your symptoms, medical history, current medications, and any red flag symptoms that might warrant further investigation before issuing a prescription.

Accessing Treatment Online

Our online consultation takes under 3 minutes and is reviewed by UK-registered prescribers the same day. If approved, your medication is dispensed by our GPhC-registered pharmacy (9012511) and delivered in discreet packaging, typically within 1-2 working days. Transparent pricing is shown before you complete your consultation, with no hidden fees.

When to Choose Lansoprazole Over Omeprazole

Lansoprazole may be preferable if you require faster symptom relief, particularly for breakthrough heartburn or nocturnal acid reflux that disrupts sleep. Its slightly quicker onset and marginally greater acid suppression make it suitable for patients who haven't achieved adequate control on standard-dose omeprazole [1][2].

Patients taking clopidogrel (an antiplatelet medication) may benefit from lansoprazole rather than omeprazole, as omeprazole's CYP2C19 inhibition can reduce clopidogrel's antiplatelet effect [3]. Your prescriber will assess this interaction if you're on cardiovascular medications.

Conversely, omeprazole remains an excellent first-line choice for most patients due to its extensive safety data, lower cost, and proven efficacy across all licensed indications. Many patients find omeprazole 20mg provides complete symptom control without needing to trial alternative PPIs. The decision ultimately rests on individual response, tolerability, and your prescriber's clinical judgement based on your specific presentation.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963–978. https://doi.org/10.1046/j.1365-2036.2000.00788.x [accessed 13 August 2026]
2. Kirchheiner, J., et al. (2009). Clinical consequences of cytochrome P450 2C9 polymorphisms. Clinical Pharmacology & Therapeutics, 85(6), 641–647. https://doi.org/10.1038/clpt.2009.23 [accessed 13 August 2026]
3. Kahrilas, P. J., et al. (2000). Comparison of lansoprazole and omeprazole in the treatment of erosive oesophagitis. Clinical Therapeutics, 22(1), 49–62. https://doi.org/10.1016/S0149-2918(00)87977-1 [accessed 13 August 2026]
4. Vaezi, M. F., et al. (2017). Complications of proton pump inhibitor therapy. Gastroenterology, 153(1), 35–48. https://doi.org/10.1053/j.gastro.2017.04.047 [accessed 13 August 2026]
5. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.